# Vitrolife to acquire Igenomix for EUR 1.25B

Swedish medical technology group Vitrolife agreed to buy reproductive genetic testing services provider Igenomix for EUR 1.25 billion from private equity group EQT and other shareholders.

- Type: Acquisition
- Announced: 2021-07-08
- Where: Spain
- Value: $1.48B (1.25B EUR)
- Status: announced
- Products: reproductive genetic testing services
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [EQT](https://endata.com/companies/3219.md) (partner)
- [Vitrolife](https://endata.com/companies/56355.md) (acquirer)
- [Igenomix](https://endata.com/companies/56356.md) (target)

## Sources

- [reuters.com](https://www.reuters.com/article/world/europe/swedens-vitrolife-to-buy-igenomix-in-eur-125-billion-deal-idUSKCN2EE1YH/), 2021-07-08: "Swedish medical technology group Vitrolife said on Thursday it would buy reproductive genetic testing services provider Igenomix S.L. in a deal worth 1.25 billion euros ($1.48 billion)."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.